Transcriptional silencing of the Wnt-antagonist DKK1 by promoter methylation is associated with enhanced Wnt signaling in advanced multiple myeloma.
The Wnt/β-catenin pathway plays a crucial role in the pathogenesis of various human cancers. In multiple myeloma (MM), aberrant auto-and/or paracrine activation of canonical Wnt signaling promotes proliferation and dissemination, while overexpression of the Wnt inhibitor Dickkopf1 (DKK1) by MM cells...
Main Authors: | Kinga A Kocemba, Richard W J Groen, Harmen van Andel, Marie José Kersten, Karène Mahtouk, Marcel Spaargaren, Steven T Pals |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3281831?pdf=render |
Similar Items
-
Roles of Wnt3a and Dkk1 in experimental periodontitis
by: Jianqi Liu, et al.
Published: (2017-09-01) -
DKK3 CAN PREVENT CARTILAGE DEGRADATION AND MODULATE TGFBETA AND WNT SIGNALLING
by: Snelling, S, et al.
Published: (2012) -
Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1.
by: Fowler, J, et al.
Published: (2012) -
Prognostic relevance of Wnt-inhibitory factor-1 (<it>WIF1</it>) and Dickkopf-3 (<it>DKK3</it>) promoter methylation in human breast cancer
by: Hartmann Arndt, et al.
Published: (2009-07-01) -
Wnt signaling: bone's defense against myeloma.
by: Edwards, C
Published: (2008)